| 1 |
29907952 | BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review. | 2018 Aug |
1 |
| 2 |
30226552 | Decreased human antigen R expression confers resistance to tyrosine kinase inhibitors in epidermal growth factor receptor-mutant lung cancer by inhibiting Bim expression. | 2018 Nov |
2 |
| 3 |
23270470 | Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines. | 2013 Mar |
5 |
| 4 |
20237869 | BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer. | 2011 Jun |
2 |
| 5 |
22157681 | EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. | 2011 Dec 11 |
1 |
| 6 |
19934277 | Bim-targeted cancer therapy: a link between drug action and underlying molecular changes. | 2009 Dec |
1 |
| 7 |
17973572 | BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. | 2007 Oct |
2 |
| 8 |
17973573 | Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. | 2007 Oct |
1 |